Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12.
about
Next generation mapping reveals novel large genomic rearrangements in prostate cancerThe co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness.Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience.Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases.Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma.Molecular characteristics of uterine sarcomas.Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families.Retrotransposon-derived p53 binding sites enhance telomere maintenance and genome protection.Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.Integrative genomic and transcriptomic analysis of leiomyosarcoma.Combination approach for detecting different types of alterations in circulating tumor DNA in leiomyosarcoma.Immune checkpoint inhibitors in sarcomas: in quest of predictive biomarkers.Soft Tissue and Uterine Leiomyosarcoma.Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.Alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.
P2860
Q33618785-6C9CECFA-9B49-4F54-88EE-F3945CA86CDBQ33626781-43DEA7ED-63C9-451E-A0A9-615A13C90C13Q38599122-CE884E1B-BBC7-4DD3-A86B-CBF1E95FA068Q38700667-4678B9D0-BBB6-45AB-914B-BE554C9483BEQ38780469-BBE7C93A-6991-49F3-B5C1-D757CDA11B51Q38881796-C0CA9B0A-EBC9-4091-B183-B3BECBAF864CQ40070779-1B838386-7F1F-4510-B6EE-E2238923CF36Q41633913-51B89C1B-E51A-497D-B782-5EB5D8979C6DQ42341131-2DB732E3-1494-4079-A825-217683671E6CQ47736062-84F27297-F8A8-4B9B-9B4F-F30AAF462563Q47739736-FF993DF1-9ADE-436C-BFCE-1A930673195BQ49791875-7130DA21-B570-4ECF-A56E-60370E7FF61EQ49859661-D60F0A79-08B3-4F36-9D5C-EA327B76E523Q50004094-0055092F-1769-4C3D-9776-1373993565FAQ52320253-AE32958A-D7A8-4DA5-BA8D-FC91DA472BC7Q54985797-6F9F1F9A-B8CB-4DA3-95A8-D5C42B04F123
P2860
Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Exome Sequencing of Uterine Le ...... ions in TP53, ATRX, and MED12.
@ast
Exome Sequencing of Uterine Le ...... ions in TP53, ATRX, and MED12.
@en
type
label
Exome Sequencing of Uterine Le ...... ions in TP53, ATRX, and MED12.
@ast
Exome Sequencing of Uterine Le ...... ions in TP53, ATRX, and MED12.
@en
prefLabel
Exome Sequencing of Uterine Le ...... ions in TP53, ATRX, and MED12.
@ast
Exome Sequencing of Uterine Le ...... ions in TP53, ATRX, and MED12.
@en
P2093
P2860
P1433
P1476
Exome Sequencing of Uterine Le ...... tions in TP53, ATRX, and MED12
@en
P2093
Jussi Taipale
Mervi Aavikko
Minna Taipale
Pia Vahteristo
Ralf Bützow
Riitta Koivisto-Korander
P2860
P304
P356
10.1371/JOURNAL.PGEN.1005850
P577
2016-02-18T00:00:00Z